Author

KL Blackwell

Observed institutions: University of Messina, University of North Carolina at Chapel Hill, Brigham and Women's Hospital, Fox Chase Cancer Center, University of Maryland Medical Center, Mayo Clinic, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Harvard University, University of Padua, Johns Hopkins University, University of Miami, Orlando Health, Duke University, University of Alabama, University of California, San Francisco, Universität Ulm, Washington University in St. Louis, Curtin University, University of Michigan, Sheba Medical Center, Universitair Ziekenhuis Leuven, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Jewish General Hospital, Carolinas Medical Center, University of Alabama at Birmingham, NYU Langone Health, Massachusetts General Hospital, Celsion (United States), Sarah Cannon, University of Miami Health System, Adaptive Biotechnologies (United States), Highlands Oncology Group, Istituto Oncologico Veneto, University of California San Francisco Medical Center, Masaryk Memorial Cancer Institute, Dana-Farber Cancer Institute, Virginia Cancer Specialists, University of North Carolina Hospitals, Duke Medical Center, Dana-Farber/Harvard Cancer Center, Washington University Medical Center, The US Oncology Network, University Hospital Ulm, Sidney Kimmel Comprehensive Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Duke Cancer Institute, UNC Lineberger Comprehensive Cancer Center, Georgetown Lombardi Comprehensive Cancer Center, National Comprehensive Cancer Network, Indiana University School of Medicine, Cross Cancer Institute, Lady Davis Institute for Medical Research, McGill University, New York University, Indiana University
OpenAlex ID: A5113588047
Works count: 16
Citation count: 45
H-index: 4
I10-index: 1
Year
Topic
Type